10577 Results

Webcast

SGRT on 4D dynamic approach: facts and trends

Authors: Filipe Moura

Congress Abstract

OLI-P trial: pattern of progression after radiotherapy in PSMA-PET positive METs of prostate cancer

Authors:

Tobias Hölscher1, Michael Baumann2, Jörg Kotzerke3, Manfred Wirth4, Christian Thomas4, Daniel Zips5, Steffen Löck6, Mechthild Krause7,9,10, Fabian Lohaus8

1Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 2_, German Cancer Research Center (DKFZ), Heidelberg, Germany; 3Department of Nuclearmedicine, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden , Dresden, Germany; 4Department of Urology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden , Dresden, Germany; 5Department of Radiation Oncology, Universität Tübingen, Tübingen, Germany; 6OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany; 7Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden , Dresden, Germany; 8Department of Radiotherapy and Radiation Oncology,, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; 9National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany, and; Helmholtz Association / Helmholtz-Zentrum Dresden – Rossendorf (HZDR), Dresden, Germany; 10German Cancer Consortium (DKTK), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Germany

Show Affiliations

Congress Abstract

A dosimetric comparison of two external beam radiotherapy techniques: 3DCRT & Tomotherapy in APBI

Authors:

Rajasree Rajan1, Beena Kunheri1, Soumya N2, Greeshma C R3

1Amrita Institute of Medical Sciences, Department of Radiation Oncology, Kochi, India; 2Amrita Institute of Medical Sciences, Department of Radiation Physics, Kochi, India; 3Amrita Institute of Medical Sciences, Department of Biostatistics, Kochi , India

Show Affiliations

Journal Article

Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac

Authors: D.M. Muinck Keizer, T. Willigenburg, J.R.N. der Voort van Zyp, B.W. Raaymakers, J.J.W. Lagendijk, J.C.J. Boer

Journal Article

Corrigendum to “Including anatomical variations in robust optimization for head and neck proton therapy can reduce the need of adaptation” [Radiother Oncol 131 (2019) 127–134]

Authors: Macarena Cubillos-Mesías, Esther G.C. Troost, Fabian Lohaus, Linda Agolli, Maximilian Rehm, Christian Richter, Kristin Stützer

Journal Article

Two-year toxicity of simultaneous integrated boost in hypofractionated prone breast cancer irradiation: Comparison with sequential boost in a randomized trial

Authors: Hans Van Hulle, Eline Desaunois, Vincent Vakaet, Leen Paelinck, Max Schoepen, Giselle Post, Annick Van Greveling, Bruno Speleers, Marc Mareel, Wilfried De Neve, Chris Monten, Pieter Deseyne, Liv Veldeman

Journal Article

A systematic review exploring the role of modern radiation for the treatment of Hereditary or Familial Breast Cancer

Authors: Varshu Goel, Dayanand Sharma, Aman Sharma, Supriya Mallick

Journal Article

Stereotactic ablative radiotherapy after concomitant chemoradiotherapy in non-small cell lung cancer: A TITE-CRM phase 1 trial

Authors: Jérôme Doyen, Michel Poudenx, Jocelyn Gal, Josiane Otto, Caroline Guerder, Arash O. Naghavi, Anais Gérard, Axel Leysalle, Charlotte Cohen, Bernard Padovani, Antoine Ianessi, Renaud Schiappa, Emmanuel Chamorey, Pierre-Yves Bondiau

Webcast

Role of the immune system in radiation therapy

Authors: Martin Pruschy
*:*